Medicament for treating idiopathic thrombocytopenic purpura

Details Medicament for treating idiopathic thrombocytopenic purpura Medicament for treating idiopathic thrombocytopenic purpura

1995-02-16

1997-07-01

Weddington, Kevin E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

A61K 3133

Patent

active

056439016

ABSTRACT:
Macrolide compounds such as the FR-900506 and its related compounds are provided for the prevention or treatment of idiopathic thrombocytopenic purpura and Basedow's disease. Composition containing such compounds is also disclosed.

REFERENCES:
patent: 4929611 (1990-05-01), Okuhara et al.
Klinische Wochenschrift, vol. 68, (Suppl. XXI):III, 1990, (Pathophysiology and Pharmacotherapy of Autoimmune Diseases, Satellite Symposium, Jul. 29, 1989), Springer-Verlag, D.B.J. Hermann et al: "Drugs in Autoimmune Diseases", pp. 15-25.
The Merck Manual, 15th Edition, 1987, pp. 1038-1043, Merck & Co., Inc., Rahway, NJ, US, also pp. 159-1160.
Immunology Today, vol. 10, No. 1, Jan. 1989, A.W. Thomson: "FK-506--How Much Potential?", pp. 1-32.
Immunology, vol. 69, No. 2, Feb. 1990, K. Yamamoto et al: "Experimental Treatment of Autoimmune MRL-1pr Mice with Immunosuppressive Compound FK506", pp. 222-227.
Current Opinion in Immunology, vol. 2, No. 6, 1990, Current Biology Ltd., St.J. Collier: "Immunosuppressive Drugs", pp. 854-858.

Affiliated with

Also associated with

Rating

Medicament for treating idiopathic thrombocytopenic purpura does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Medicament for treating idiopathic thrombocytopenic purpura, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament for treating idiopathic thrombocytopenic purpura will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-597272